25 May 2025 in Russian Military Medical Academy Reports
Background: The development of agents aimed at achieving hemostasis in parenchymal organ bleeding remains one of the current challenges in medicine. Chitosan-based sponges are considered a promising approach to achieving effective hemostasis. The safety of these products was previously demonstrated in a 60-day experiment in rats. AIM: To evaluate the efficacy and safety of chitosan-based hemostatic sponge samples in a standardized liver trauma model in pigs during a long-term experiment. MATERIALS AND METHODS: The study was conducted in three same-sex pigs. A standardized model of intraperitoneal bleeding was created using laparoscopic access, followed by the application of a chitosan-based hemostatic sponge, which was left in the abdominal cavity for the entire duration of the experiment. The animals were observed for 60 days, during which general condition, body weight, and complete blood count were monitored. On day 30, repeat laparoscopy was performed to visually inspect the trauma site. At the end of the observation period, the animals were euthanized. RESULTS: The hemostatic sponge provided complete hemostasis of parenchymal bleeding, with no recurrence of bleeding. No behavioral abnormalities were observed in animals throughout the entire experiment. Blood parameters remained within reference ranges. On day 30, repeat laparoscopy revealed adhesion formation and encapsulation of the hemostatic sponge in the peritoneal cavity. Histological examination of liver tissue on day 60 revealed an increased number of inflammatory cells at the site of contact with the hemostatic sponge. Maturation of granulomatous connective tissue in the liver was also observed, suggesting active wound healing. CONCLUSION: The developed chitosan-based hemostatic sponge demonstrated both efficacy and biocompatibility, which allow it to remain in the abdominal cavity throughout medical evacuation. However, subsequent removal is recommended to prevent adhesion formation and potential peritoneal inflammation.
3 December 2024 in Bulletin of Rehabilitation Medicine
INTRODUCTION. The relevance of the study is due to the increase in the number of human skin lesions as a result of natural and man-made emergencies. Among the natural polymers widely used for the manufacture of wound dressings is chitosan, but its poor solubility is a technological and biological limitation for its effective inclusion and use as a component of wound dressings. One way to solve the problem is to modify chitosan with glycolic, lactic or ascorbic acids. For eff ective and adequate use of chemical modifications of chitosan as a material for wound dressings, it is necessary to evaluate their biocompatibility. AIM. In vitro assessment of the cytotoxicity and hemostatic properties of sponges based on chitosan modified with glycolic, lactic and ascorbic acids. MATERIALS AND METHODS. Sponges based on water-soluble chitosan salts were provided by Chemical Company “Orion” LTD. The biocompatibility of the obtained products was assessed on the culture of mesenchymal stem cells, using light and fluorescent microscopy. The metabolic activity of the cells (MTT-test) and the sorption properties of the biomaterials were assessed by spectrophotometry. RESULTS AND DISCUSSION. Chitosan glycolate or chitosan lactate sponges ensure the survival of most adherent cells, while chitosan ascorbate sponges inhibit cell viability and growth. It was found that chitosan glycolate sponges have the highest blood sorption capacity and are capable of absorbing over 700 μl of blood/cm3. Chitosan lactate and chitosan ascorbate sponges demonstrate a sorption capacity of 250 μl of blood/cm3. However, the ascorbate-based material inhibits the metabolic activity of cells. CONCLUSION. Based on the research results, sponges made of chitosan glycolate or lactate, which have good biocompatibility in vitro, can be used for further development of wound-healing coatings. In addition, sponges made of chitosan glycolate can be used as highly effective hemostatic materials. Sponges made of chitosan ascorbate require further development and separate study.